NCT04387084 2026-03-23Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin MalignancyUniversity of Southern CaliforniaPhase 1 Active not recruiting10 enrolled
NCT04139902 2025-10-15Neoadjuvant PD-1 Inhibitor Dostarlimab (TSR-042) vs. Combination of Tim-3 Inhibitor Cobolimab (TSR-022) and PD-1 Inhibitor Dostarlimab (TSR-042) in MelanomaUniversity of PittsburghPhase 2 Active not recruiting48 enrolled